Page 11 - Shimadzu Journal vol.9 Issue2

“Our partnership is a great support to advance research in oncology” | INSIGHT from CUSTOMER

Dr. Noel Zahr

How are Shimadzu instruments What are Shimadzu’s strengths
helping you in your research? compared to other vendors?

First of all, regarding sample preparation, the nSMOL Apart from this collaboration, the Shimadzu instruments
kit was very easy to use by technicians. The sample are robust and sensitive. In our laboratory, where many
preparation time was well optimized in order to finalize routine tests are carried out, it is important to have
all the peptide digestion steps on the same day. The robust systems well maintained over time. Shimadzu
HPLC system was very efficient. LCMS-8060 was very LCMS systems are scalable, and it’s very important when
fast, sensitive and robust which allowed us to develop we cannot objectively renew it regularly. The quality
several multiplexing method. to price ratio and the after-sales service are excellent.

Could you tell us why you chose Shimadzu as Thank you again for your time today.
your partner when you started this project? Finally, could you share any requests
that you have with respect to analytical
We have known Shimadzu Company for more than and measuring instrument vendors?
15 years through the use of their HPLC systems.
Shimadzu is a leader in the development of peptide What I can say to analytical and measuring instrument
and protein assays. Moreover, Shimadzu was the first vendors is that they must always listen to the needs of
one to offer a uni ver sal sample preparation kit for their customers, in particular to help with the develop-
mono clonal antibodies. ment of methods assay.

Dr. Noël Zahr, pharmacologist-biolo- Dr. Zahr holds a Master's degree in research and a PhD in phar-
gist, he is the head of the “Pharmacoki- macology. His main line of research is the evaluation of the cor-
netics and Therapeutic Pharmacological relation between a clinical event (toxicity, lack of efficacy) and the
Monitoring” unit and the Therapeutic plasma concentrations of drugs.
Drug Monitoring Laboratory in Assis-
tance Publique–Hôpitaux de Paris (AP-
HP), Pitié Salpetrière Hospital since 2012,

Shimadzu Journal vol.9 Issue2 44